Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster is a research paper published in New England Journal of Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 271 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Woodruff Health Sciences Center
Grant: 2020 COVID-19 CURE
National Institute of Allergy and Infectious Diseases
Grant: 1U54CA260563
National Institute of Allergy and Infectious Diseases
Grant: 3U19AI057266-17S1
Vaccine Induced Immunity in the Young and Aged
National Institute of Allergy and Infectious Diseases
Grant: 75N93021C00017
National Institute of Allergy and Infectious Diseases
Grant: HHSN272201400004C
National Institute of Allergy and Infectious Diseases
Grant: P51OD011132
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: Intramural funding
NCI NIH HHS
Grant: U54 CA260563
NIAID NIH HHS
Grant: U19 AI057266
National Institutes of Health
Grant: 3P51OD011132-64S2
Renovation to expand and enhance NHP housing for HIV/AIDS research at the Emory NPRC
National Institutes of Health
Grant: 1U54CA260563-01
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
COVID-Catalyst-I Funds from the Woodruff Health Sciences Center and Emory School of Medicine
Pediatric Research Alliance Center for Childhood Infections and Vaccines and Children’s Healthcare of Atlanta
Emory Executive Vice President for Health Affairs Synergy Fund award
FWCI
40.74
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords